CD81 Enhances Radioresistance of Glioblastoma by Promoting Nuclear Translocation of Rad51

CD81 Enhances Radioresistance of Glioblastoma by Promoting Nuclear Translocation of Rad51

Glioblastoma (GBM) is the most common type of primary tumor in central nervous system in adult with a 5-year survival rate of ≤5%. Despite of recent advances in tumor radiotherapy, the prognosis of GBM remains to be dismal due to radioresistance. In this study, we identified CD81 as a potential biom...

Full description

Bibliographic Details
Main Authors: Wang Zheng, Qianping Chen, Hongxia Liu, Songling Hu, Yuchuan Zhou, Yang Bai, Jianghong Zhang, Yan Pan, Chunlin Shao
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
glioblastoma
radioresistance
CD81 regulation
Rad51 nuclear translocation
Online Access:https://www.mdpi.com/2072-6694/13/9/1998

Similar Items

Similar Items